Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Working Capital Changes (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Other Working Capital Changes for 16 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 2327.78% to -$1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.3 million through Dec 2025, down 317.03% year-over-year, with the annual reading at -$2.3 million for FY2025, 317.03% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$1.3 million at Anika Therapeutics, down from -$219000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.8 million in Q4 2022, with the low at -$2.0 million in Q3 2022.
  • Average Other Working Capital Changes over 5 years is -$203850.0, with a median of -$74500.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes plummeted 270259.86% in 2021, then soared 1466.67% in 2022.
  • Over 5 years, Other Working Capital Changes stood at $440000.0 in 2021, then soared by 319.55% to $1.8 million in 2022, then plummeted by 86.02% to $258000.0 in 2023, then tumbled by 120.93% to -$54000.0 in 2024, then crashed by 2327.78% to -$1.3 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.3 million, -$219000.0, and -$1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.